NFKB1 and infection: In in vitro studies, subsequent to infection with SARS-CoV, NF-κB was reported to switch on in mice lungs and in human macrophages; on the contrary, NF-κB inhibition decreased inflammation and ameliorates survival in SARS-CoV-infected mice [180,181].